vs

Side-by-side financial comparison of ASSEMBLY BIOSCIENCES, INC. (ASMB) and Falcon's Beyond Global, Inc. (FBYD). Click either name above to swap in a different company.

ASSEMBLY BIOSCIENCES, INC. is the larger business by last-quarter revenue ($10.8M vs $6.6M, roughly 1.6× Falcon's Beyond Global, Inc.). Falcon's Beyond Global, Inc. runs the higher net margin — -4.5% vs -85.2%, a 80.7% gap on every dollar of revenue. On growth, Falcon's Beyond Global, Inc. posted the faster year-over-year revenue change (383.5% vs 57.6%). Falcon's Beyond Global, Inc. produced more free cash flow last quarter ($-4.3M vs $-15.2M).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

500 Global is an early-stage venture fund and seed accelerator founded in 2010 by Dave McClure and Christine Tsai. The fund admitted a first "class" of twelve startups to its incubator office in Mountain View, California in February 2011. They expanded to a second class of 21 in June 2011 and a third class of 34 in October 2011. 500 Global has $2.3 billion in assets under management (AUM) as of March 2024.

ASMB vs FBYD — Head-to-Head

Bigger by revenue
ASMB
ASMB
1.6× larger
ASMB
$10.8M
$6.6M
FBYD
Growing faster (revenue YoY)
FBYD
FBYD
+325.9% gap
FBYD
383.5%
57.6%
ASMB
Higher net margin
FBYD
FBYD
80.7% more per $
FBYD
-4.5%
-85.2%
ASMB
More free cash flow
FBYD
FBYD
$10.8M more FCF
FBYD
$-4.3M
$-15.2M
ASMB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASMB
ASMB
FBYD
FBYD
Revenue
$10.8M
$6.6M
Net Profit
$-9.2M
$-296.0K
Gross Margin
Operating Margin
-100.9%
-30.9%
Net Margin
-85.2%
-4.5%
Revenue YoY
57.6%
383.5%
Net Profit YoY
4.3%
97.5%
EPS (diluted)
$-0.72
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASMB
ASMB
FBYD
FBYD
Q4 25
$6.6M
Q3 25
$10.8M
$4.1M
Q2 25
$9.6M
$2.5M
Q1 25
$9.4M
$1.7M
Q4 24
$7.4M
$1.4M
Q3 24
$6.8M
$2.1M
Q2 24
$8.5M
$1.8M
Q1 24
$5.8M
$1.5M
Net Profit
ASMB
ASMB
FBYD
FBYD
Q4 25
$-296.0K
Q3 25
$-9.2M
$-10.4M
Q2 25
$-10.2M
$25.1M
Q1 25
$-8.8M
$-8.1M
Q4 24
$-11.9M
Q3 24
$-9.6M
$39.3M
Q2 24
$-11.2M
$8.0M
Q1 24
$-9.1M
$114.0M
Operating Margin
ASMB
ASMB
FBYD
FBYD
Q4 25
-30.9%
Q3 25
-100.9%
-90.9%
Q2 25
-115.2%
-53.0%
Q1 25
-105.5%
-371.1%
Q4 24
-335.6%
Q3 24
-160.1%
-118.9%
Q2 24
-143.0%
-195.9%
Q1 24
-185.5%
-350.5%
Net Margin
ASMB
ASMB
FBYD
FBYD
Q4 25
-4.5%
Q3 25
-85.2%
-256.8%
Q2 25
-105.9%
985.2%
Q1 25
-93.6%
-473.8%
Q4 24
-871.7%
Q3 24
-140.4%
1899.5%
Q2 24
-130.7%
446.5%
Q1 24
-156.9%
7521.4%
EPS (diluted)
ASMB
ASMB
FBYD
FBYD
Q4 25
$-0.01
Q3 25
$-0.72
$-0.13
Q2 25
$-1.33
$0.30
Q1 25
$-1.17
$-0.13
Q4 24
$-0.25
Q3 24
$-1.51
$0.39
Q2 24
$-1.98
$0.00
Q1 24
$-1.66
$1.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASMB
ASMB
FBYD
FBYD
Cash + ST InvestmentsLiquidity on hand
$22.5M
$1.9M
Total DebtLower is stronger
$15.6M
Stockholders' EquityBook value
$182.7M
$11.9M
Total Assets
$240.0M
$66.7M
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASMB
ASMB
FBYD
FBYD
Q4 25
$1.9M
Q3 25
$22.5M
$4.3M
Q2 25
$24.0M
$26.1M
Q1 25
$23.4M
$1.1M
Q4 24
$38.3M
$825.0K
Q3 24
$28.5M
$828.0K
Q2 24
$19.2M
$1.7M
Q1 24
$18.7M
$1.1M
Total Debt
ASMB
ASMB
FBYD
FBYD
Q4 25
$15.6M
Q3 25
Q2 25
Q1 25
Q4 24
$41.2M
Q3 24
$10.3M
Q2 24
$15.7M
Q1 24
$15.1M
Stockholders' Equity
ASMB
ASMB
FBYD
FBYD
Q4 25
$11.9M
Q3 25
$182.7M
$9.2M
Q2 25
$18.1M
$414.0K
Q1 25
$27.1M
$-11.6M
Q4 24
$33.4M
$-9.0M
Q3 24
$26.0M
$-1.4M
Q2 24
$34.7M
$-44.7M
Q1 24
$32.6M
$-61.7M
Total Assets
ASMB
ASMB
FBYD
FBYD
Q4 25
$66.7M
Q3 25
$240.0M
$66.8M
Q2 25
$80.8M
$89.2M
Q1 25
$99.0M
$56.7M
Q4 24
$119.2M
$61.2M
Q3 24
$100.3M
$66.5M
Q2 24
$115.3M
$65.9M
Q1 24
$119.9M
$67.8M
Debt / Equity
ASMB
ASMB
FBYD
FBYD
Q4 25
1.31×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASMB
ASMB
FBYD
FBYD
Operating Cash FlowLast quarter
$-15.1M
$-4.3M
Free Cash FlowOCF − Capex
$-15.2M
$-4.3M
FCF MarginFCF / Revenue
-140.7%
-66.0%
Capex IntensityCapex / Revenue
0.4%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASMB
ASMB
FBYD
FBYD
Q4 25
$-4.3M
Q3 25
$-15.1M
$-13.3M
Q2 25
$-16.8M
$-7.9M
Q1 25
$-23.4M
$945.0K
Q4 24
$-51.1M
$-3.8M
Q3 24
$-15.2M
$-2.4M
Q2 24
$-17.1M
$-2.6M
Q1 24
$-18.4M
$-3.8M
Free Cash Flow
ASMB
ASMB
FBYD
FBYD
Q4 25
$-4.3M
Q3 25
$-15.2M
$-13.4M
Q2 25
Q1 25
$853.0K
Q4 24
$-51.1M
$-3.8M
Q3 24
$-2.4M
Q2 24
$-17.1M
$-2.6M
Q1 24
$-18.4M
$-3.8M
FCF Margin
ASMB
ASMB
FBYD
FBYD
Q4 25
-66.0%
Q3 25
-140.7%
-329.6%
Q2 25
Q1 25
49.9%
Q4 24
-695.2%
-278.7%
Q3 24
-114.9%
Q2 24
-200.6%
-145.6%
Q1 24
-317.7%
-248.8%
Capex Intensity
ASMB
ASMB
FBYD
FBYD
Q4 25
0.3%
Q3 25
0.4%
1.0%
Q2 25
0.0%
0.0%
Q1 25
0.0%
5.4%
Q4 24
0.4%
0.1%
Q3 24
0.0%
0.2%
Q2 24
0.2%
0.1%
Q1 24
0.2%
0.3%
Cash Conversion
ASMB
ASMB
FBYD
FBYD
Q4 25
Q3 25
Q2 25
-0.31×
Q1 25
Q4 24
Q3 24
-0.06×
Q2 24
-0.33×
Q1 24
-0.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons